Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13439770 | 0.87 | LTA4H (0.44) | LTA4HCA2CA12CA1CA14 | |
| SCHEMBL20760705 | 0.86 | LTA4H (0.36) | LTA4HCA2CA12CA1CA14 | |
| SCHEMBL14195997 | 0.79 | CA1 (0.32) | CA1 | |
| SCHEMBL2274095 | 0.77 | NPSR1 (0.39) | CA2CA12CA1CA14 | |
| SCHEMBL12853799 | 0.77 | NLRP3 (0.33) | CA1 | |
| SCHEMBL17832923 | 0.76 | LTA4H (0.39) | LTA4HCA2CA12CA1CA14 | |
| SCHEMBL425349 | 0.76 | — | — | |
| SCHEMBL24624716 | 0.75 | — | — | |
| SCHEMBL9116990 | 0.75 | LTA4H (0.37) | LTA4H | |
| Ammonia Solution, Strong SCHEMBL27689607 | 0.74 | ALDH1A1 (0.36) | LTA4HCA2CA12CA1CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050261332-A1 | Sulfonamides and uses thereof | ELIXIR PHARMACEUTICALS, INC. | 2005-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261332-A1 | Sulfonamides and uses thereof | GLS2, STS, ABAT | LTA4H 1506/4885CA2 3211/4885CA12 1474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.